Streetbeat News

Legal Regulatory

RKLB

Rosen Law Firm is seeking lead plaintiffs for a class action lawsuit against Rocket Lab USA, Inc. (RKLB) alleging the company made false or misleading statements during the period of November 12, 2024 to February 25, 2025. The lawsuit claims Rocket Lab misrepresented its Neutron rocket launch timeline, barge landing tests, launch pad preparation, and contract details.

Portfolio Pulse from

March 26, 2025 | 9:30 pm

APP

A class action securities lawsuit has been filed against AppLovin Corporation (APP) alleging securities fraud between May 10, 2023 and February 25, 2025. The lawsuit claims the company artificially inflated its financial performance by exploiting advertising data from Meta Platforms and using manipulative practices to boost ad click-through and app download rates. Following these allegations, APP's stock price dropped from $377.06 to $331.00 per share.

Portfolio Pulse from

March 26, 2025 | 9:30 pm

MPWR

A class action securities lawsuit has been filed against Monolithic Power Systems Inc. (MPWR) alleging securities fraud between February and November 2024. The lawsuit claims the company made false statements and concealed significant performance and quality control issues with voltage regulator modules and power management integrated circuits, which negatively impacted products for their largest customer, Nvidia.

Portfolio Pulse from

March 26, 2025 | 9:30 pm

TIXT

Rosen Law Firm is preparing a class action lawsuit against TELUS International (Cda) Inc. for allegedly misleading investors about its AI Data Solutions strategy. The lawsuit claims the company failed to disclose how its AI development was impacting profitability and margins during the period from February 16, 2023 to August 1, 2024.

Portfolio Pulse from

March 26, 2025 | 9:30 pm

ZYXI

Wolf Haldenstein Adler Freeman & Herz LLP has initiated a securities class action lawsuit against Zynex, Inc. (ZYXI) on behalf of shareholders who purchased stock between March 13, 2023, and March 11, 2025. The lawsuit suggests potential legal challenges for the company related to securities transactions during this period.

Portfolio Pulse from

March 26, 2025 | 9:30 pm

SLNO

Soleno Therapeutics has received FDA approval for VYKAT XR, an extended-release tablet designed to treat hyperphagia in adults and children 4 years and older with Prader-Willi syndrome. This marks the first approved therapy specifically addressing this condition, potentially representing a significant milestone for the company and patients.

Portfolio Pulse from

March 26, 2025 | 9:30 pm

ESTC

A class action lawsuit has been filed against Elastic N.V. alleging securities fraud between May 31, 2024 and August 29, 2024. The complaint claims the company made false statements about its sales operations, revenue guidance, and overall financial stability during this period.

Portfolio Pulse from

March 26, 2025 | 9:30 pm

ATKR

A class action lawsuit has been filed against Atkore (ATKR) alleging anticompetitive price-fixing in the PVC pipe market. The lawsuit claims the company artificially inflated pipe prices during the COVID-19 pandemic, which was exposed by a short seller report. Following the allegations, Atkore's stock dropped 20% after reporting lower-than-expected earnings and reducing fiscal year guidance.

Portfolio Pulse from

March 26, 2025 | 9:30 pm

TMDX

A class action securities lawsuit has been filed against TransMedics Group, Inc. (TMDX) for alleged securities fraud between February 28, 2023 and January 10, 2025. The lawsuit claims the company used fraudulent business practices, including kickbacks, overbilling, and unsafe practices, which exposed the company to regulatory risks.

Portfolio Pulse from

March 26, 2025 | 9:30 pm

MRVI

Levi & Korsinsky law firm has filed a class action securities lawsuit against Maravai LifeSciences Holdings, Inc. alleging securities fraud between August 7, 2024 and February 24, 2025. The lawsuit claims the company made false statements and had inadequate internal controls over financial reporting, potentially misrepresenting revenue recognition, goodwill valuation, and overall business prospects.

Portfolio Pulse from

March 26, 2025 | 9:15 pm